Shindo Y, Fuchs AG, Davis CG, Eitas T, Unsinger J, Burnham CA, Green JM, Morre M, Bochicchio GV, Hotchkiss RS. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. J Leukoc Biol. 2017. 101. 531-542
Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo MI. Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulm Med. 2016. 22. 219-226
Macrolide therapy for patients with pneumonia: a triple-edged sword. In: Aliberti S, Chalmers JD, Pletz M, eds. Anti-infectives and the Lung (ERS Monograph)
European Respiratory Society 2017
新 呼吸器専門医テキスト. 各論I 気道・肺疾患 E. 肺化膿症
南江堂 2015
呼吸器病レジデントマニュアル (第5版). 第3章 主な呼吸器疾患の診断と治療 A. 肺感染症 2. 市中肺炎
医学書院 2015
Immunotherapeutic strategies for sepsis and pneumonia
(The International Respiratory Infections Conference 2017 2017)
Risk Factors for Severe Adverse Outcomes in Patients with Hospital-Acquired Pneumonia
(American Thoracic Society 2017 International Conference 2017)
An extra-pulmonary etiology of non-resolving pneumonia
(European Respiratory Society International Congress 2016 2016)
Interleukin 7 immunotherapy improves survival in sepsis followed by secondary Pseudomonas aeruginosa pneumonia
(American Thoracic Society 2016 International Conference 2016)
ACCP日本部会
, European Respiratory Society
, American College of Chest Physician
, American Thoracic Society
, 日本アレルギー学会
, 日本呼吸ケア・リハビリテーション学会
, 日本集中治療医学会
, 日本結核病学会
, 日本化学療法学会
, 日本感染症学会
, 日本呼吸器学会
, 日本内科学会